查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133521

全球醫學圖像分析軟件市場-2022-2029

Global Medical Image Analysis Software Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

市場增長受到多種因素的推動，包括醫學成像系統的新技術進步、計算機輔助診斷應用的增加以及由於慢性病患病率上升而導致的成像設備使用量增加。

醫學成像系統的新興技術進步將推動市場增長。

醫學影像的技術進步，例如人工智能 (AI) 和機器學習 (ML) 的擴展，例如通過 CT 掃描檢測中風，限制了中風的治療時間，因此 AI 可以確定將患者轉移到前線並改善結果的特徵。擴大使用基於雲的建模軟件、3D 全息模型。查看完整的解剖細節，包括器官及其內部結構的空間關係，並動態考慮不同結構內的器官血管、腫瘤和異常。這種全息模型有助於術前計劃並大大提高手術準確性。此外，通過自動化圖像和其他數據的關聯和集成，ML 使放射科醫師能夠自動化放射成像中的查找和解釋、質量控制、查找和解釋以及劑量估計。此外，POC 幫助放射科醫生、護理人員、醫生和患者做出數據驅動的決策，以加快診斷和治療。

嚴格的 FDA 法規和隱私安全問題預計將抑制全球醫學圖像分析軟件市場的增長。

但是，受 FDA 嚴格法規的影響，隱私和安全問題將在預測期內阻礙全球市場增長。

COVID-19 影響分析

COVID-19 的影響是一場獨一無二的健康危機，對醫學圖像分析軟件市場的全球市場增長產生了巨大影響。 COVID-19 正在為醫學圖像分析軟件市場提供更大的潛力。例如，COVID-19 促使我們重申數字醫療的新現實。這場大流行凸顯了對虛擬護理干預的迫切需求，以減少獲得醫療保健的障礙。此外，在大流行期間，物理訪問一直是一個問題，其中包括不同的平台，例如醫學影像分析軟件，以抵禦任何預期的損害並更快地診斷中風患者。增加對診斷的關注。

內容

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 推進技術創新
      • 提高認識
    • 約束因素
      • 高成本
      • 安全和隱私問題
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按應用程序

  • 循環區
  • 腫瘤學
  • 骨科
  • 泌尿科/腎臟科
  • 婦產科
  • 乳房 X 光檢查
  • 其他

第 8 章按圖像類型

  • 二維圖像
  • 3D 圖像
  • 4D 圖像

第九章技術

  • 磁共振成像 (MRI)
  • 超聲成像
  • 計算機斷層掃描 (CT)
  • 單光子發射計算機斷層掃描 (SPECT)
  • 正電子發射斷層掃描 (PET)
  • X 射線診斷成像
  • 組合模式
  • 其他

第十章安裝工具

  • 桌面
  • 手機/平板電腦

第 11 章，最終用戶

  • 醫院和診所
  • 診斷中心
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
      • 印度
      • 日本
      • 澳大利亞
      • 其他亞太地區
  • 中東和非洲

第 13 章市場 - 競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 14 章市場 - 公司簡介

  • GE Healthcare
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Philips Healthcare,
  • Toshiba Medical Systems Corporation
  • Siemens Healthineers
  • AGFA Healthcare
  • Esaote S.P.A
  • Mim Software, Inc.
  • Aquilab
  • Carestream Health, Inc.
  • Merge Healthcare Incorporated

第15章 數據

簡介目錄
Product Code: DMHCIT232

Market Overview

Medical Image Analysis Software Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Medical image analysis software is used to analyze data from medical images aiding diagnosis, compare images between patients or within the same patient at different time points to assess the progress of the disease, and evaluate prognosis.

Market Dynamics

The market growth is driven by several factors, such as the new technological advancements in medical imaging systems, increasing applications of computer-aided diagnosis and increasing use of imaging equipment due to the rising prevalence of chronic diseases.

The new technological advancements in medical imaging systems will drive market growth.

Technological advancements in medical imaging, such as augmentations of artificial intelligence (AI) and machine learning (ML), like in the case of stroke detection through a CT scan, since strokes have a limited treatment window, the AI can identify features that move a patient to the front of the line to improve outcomes, the extended use of cloud-based modeling software, 3D holographic models that displays complete anatomical details, including spatial associations among the organs and their internal structures enabling to consider organ vasculature, neoplasms, and anomalies in-situ within distinct structures. These holographic models benefit in pre-surgery planning and greatly assist surgical precision. Furthermore, ML, through automating the correlation and integration of images with other data, will allow radiologists to detect and interpret findings, control quality, and potentially automate findings, interpretations, and dosage estimation, in radiology imaging. In addition, Point-of-care medical imaging aids radiologists, first responders, physicians, and patients in quickening diagnosis and treatment through data-driven decision-making.

The stringent FDA regulations and privacy & security concerns will restrain the global medical image analysis software market growth.

However, the market is affected by stringent FDA regulations, and privacy and security concerns will hamper the global market growth during the forecast period.

COVID-19 Impact Analysis

The COVID-19 impact is an unparalleled health crisis and has immensely impacted the medical image analysis software market's global market growth. COVID-19 has fed the medical image analysis software market with improved possibilities. For instance, COVID-19 has boosted us to rehearse the new reality of digital care. Amidst the pandemic, it is exposed that there is an urgency for virtual care interventions to reduce compromised access to healthcare. Furthermore, during the pandemic, physical visitations were problematic, which increased the focus on virtual diagnosis involving different platforms such as medical image analysis software to diagnose the patient with stroke faster, dodging any anticipated damage.

Segment Analysis

The cardiology segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cardiology segment accounted for the largest share and is projected to grow during the forecast period (2022-2029) due to the rising number of cardiac imaging tests as the number of cardiac disorders is increasing and growing advanced and innovative cardiac imaging technologies. For instance, per the World Stroke Organization, more than 13 million people are at risk of a cardiac stroke each year, and 5.5 million will be fatal. The increasing research focus on cardiac imaging tests ensures the cardiology segment's dominance. For instance, the University Hospitals and Case Western Reserve University have been working on an approach to detect heart disease via a chest x-ray. Instead of using one beam of energy, like a typical chest x-ray, their technique employs dual energy technology. Also, there are promising practices in development for higher-quality atherosclerosis imaging, like a high spatial resolution, high signal-to-noise imaging, and quantitative T1/T2 mapping for improved plaque depiction, which will one day allow physicians to peer into vessels to catch the forewarning signs of heart disease much earlier.

Geographical Analysis

The North American region holds the largest market share of the global medical image analysis software market.

North America is predicted to dominate the global market throughout the forecast period (2022-2029) since this region has an increased prevalence of cardiovascular diseases. According to the CDC, in 2020, 0ver 697,000 people in the United States died from heart disease; according to 2020 U.S. data for Out of Hospital Cardiac Arrests (OHCA), survival to hospital discharge was 9.0% for all EMS-treated non-traumatic OHCA cardiac arrests per the American Heart Association (AHA).

Furthermore, the data from the CDC shows that there are nearly 795,000 cases of stroke each year, out of which 18500 strokes are those with stroke history. Also, organizations spreading awareness about cardiovascular diseases contribute to the dominance of the North American region over the global market; a few are the Stroke Organization, National Stroke Association, Stroke Awareness Foundation, and American Stroke Association. In addition, most key market players are U.S. based, such as Mim Software, Inc., G.E. Healthcare, Carestream Health, Inc., Merge Healthcare Incorporated, Etc, which hold a large portion of the market to ensure this region's dominance.

Competitive Landscape

The medical image analysis market is moderately competitive because of the local and global players. Some key players are Philips Healthcare, Toshiba Medical Systems Corporation, GE Healthcare, Siemens Healthineers, AGFA Healthcare, Esaote S.P.A, Mim Software, Inc., Aquilab, Carestream Health, Inc., and Merge Healthcare Incorporated. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 09, 2022, Philips received FDA 510(k) clearance for the latest breakthrough high-performance MR 7700 system. Also, in August 16, 2022, Wipro and GE Healthcare Collaborated with Boston Scientific to advance cardiac care in India.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, founded in 2004. It is a subsidiary of American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

The product portfolio of GE Healthcare includes Advantage CTC Pro3D EC, AdvantageSim MD AdvantageSim MD, CardEP, Etc.

The global medical image analysis software market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Innovations
      • 4.1.1.2. Increased Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
      • 4.1.2.2. Security and Privacy Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Cardiology
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Oncology
  • 7.4. Orthopedics
  • 7.5. Urology and Nephrology
  • 7.6. Obstetrics and Gynecology
  • 7.7. Mammography
  • 7.8. Others

8. By Image Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type Segment
    • 8.1.2. Market Attractiveness Index, By Image Type Segment
  • 8.2. 2-D Image
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. 3-D Image
  • 8.4. 4-D Image

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
    • 9.1.2. Market Attractiveness Index, By Technology Segment
  • 9.2. Magnetic Resonance Imaging (MRI)
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ultrasound Imaging
  • 9.4. Computed Tomography (CT)
  • 9.5. Single-Photon Emission Computed Tomography (SPECT)
  • 9.6. Positron Emission Tomography (PET)
  • 9.7. Radiographic Imaging
  • 9.8. Combined Modalities
  • 9.9. Others

10. By Installation tool

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation Tool Segment
    • 10.1.2. Market Attractiveness Index, By Installation Tool Segment
  • 10.2. Desktop
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Mobile/Tablet

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 11.1.2. Market Attractiveness Index, By End User Segment
  • 11.2. Hospital And Clinics
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Diagnostic Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. The U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. The U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 12.5.9. China
      • 12.5.9.1. India
      • 12.5.9.2. Japan
      • 12.5.9.3. Australia
      • 12.5.9.4. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Image Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Installation tool
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Market - Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking

14. Market - Company Profiles

  • 14.1. GE Healthcare
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Philips Healthcare,
  • 14.3. Toshiba Medical Systems Corporation
  • 14.4. Siemens Healthineers
  • 14.5. AGFA Healthcare
  • 14.6. Esaote S.P.A
  • 14.7. Mim Software, Inc.
  • 14.8. Aquilab
  • 14.9. Carestream Health, Inc.
  • 14.10. Merge Healthcare Incorporated

LIST NOT EXHAUSTIVE

15. DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us